Coloplast is a leading global supplier of intimate healthcare products with a strong product portfolio and high market share. The company has a stable business model and benefits from demographic ...

We think Coloplast's urology segment could offer growth potential and cross-selling opportunities. Thus far, the firm has been more successful in the United States with its slings, kidney stone ...

Though inflationary pressures have been alleviated to some extent, Coloplast’s ongoing launches of key new products should damp operating margin until fiscal 2026. After taking another look at how ...